These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7658354)

  • 21. Development of a colonic release capsule dosage form and the absorption of insulin.
    Kraeling ME; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):199-209. PubMed ID: 1378164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.
    Niwa K; Takaya T; Morimoto T; Takada K
    J Drug Target; 1995; 3(2):83-9. PubMed ID: 7496731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
    Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
    J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique.
    Ishii K; Saitou Y; Yamada R; Itai S; Nemoto M
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1550-5. PubMed ID: 8795273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biopharmaceutical characterization of oral controlled/modified-release drug products. In vitro/in vivo correlation of roxatidine.
    Frick A; Möller H; Wirbitzki E
    Eur J Pharm Biopharm; 1998 Nov; 46(3):313-9. PubMed ID: 9885304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
    Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
    Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo evaluation of levofloxacin sustained-release capsules.
    Yin LF; Huang SJ; Jiang SG; Zhao CJ; Pei ZQ; Zhang Q
    Drug Dev Ind Pharm; 2011 Jan; 37(1):33-40. PubMed ID: 20545503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of a monolithic floating dosage form for furosemide.
    Menon A; Ritschel WA; Sakr A
    J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro-in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery.
    Tiwari D; Goldman D; Town C; Sause R; Madan PL
    Pharm Res; 1999 Nov; 16(11):1775-80. PubMed ID: 10571286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained-release dosage form of nitrofurantoin. Part 1. Preparation of microcapsules and in vitro release kinetics.
    Ertan G; Sarigüllü I; Karasulu Y; Erçakir K; Güneri T
    J Microencapsul; 1994; 11(2):127-35. PubMed ID: 8006759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). II. In vitro and in vivo evaluation.
    Morita R; Honda R; Takahashi Y
    J Control Release; 2000 Jul; 68(1):115-20. PubMed ID: 10884584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimization of a floating osmotic pump system of ambroxol hydrochloride using central composite design-response surface methodology and its pharmacokinetics in Beagle dogs].
    Zhao F; Ma YL; Jin XL; Wang J; Cao DY
    Yao Xue Xue Bao; 2011 Dec; 46(12):1507-14. PubMed ID: 22375427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.